COUGH AND RUB

咳嗽和摩擦

• 批准号: 7951307
• 负责人: IAN A. PAUL
• 金额: $ 0.14万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2010-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951307
• 关键词: Acute; Affect; Caring; Child; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Coughing; Funding; Grant; Guidelines; Institution; Left; Ointments; Oral; Parents; Patients; Petrolatum; Publishing; Research; Research Personnel; Resources; Sleep; Source; Symptoms; Therapeutic; United States; United States National Institutes of Health; Upper Respiratory Infections; Visit; treatment effect

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Cough is the most common reason for an acute care doctor's visit in the United States and may be the most bothersome symptom for children with upper respiratory tract infections (URI). It is particularly troublesome at night because it can adversely affect sleep for both coughing children and their parents. Recent studies and published guidelines have questioned the efficacy of many of the oral over-the-counter treatments for cough and cold symptoms. This has left parents and patients with limited therapeutic options. This study seeks to subjectively evaluate whether Vicks¿ VapoRub¿ (VVR) ointment and a control ointment (petrolatum) are better than no treatment at all for controlling nocturnal cough and cold symptoms in children with URI. It also will determine the effect of the treatments on sleep quality for children with URI and their parents.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 咳嗽是美国急性护理医生就诊的最常见原因，也可能是上呼吸道感染（URI）儿童最令人烦恼的症状。它在晚上特别麻烦，因为它会对咳嗽的孩子和他们的父母的睡眠产生不利影响。最近的研究和出版的指南质疑了许多口服非处方药治疗咳嗽和感冒症状的疗效。这使得父母和患者的治疗选择有限。本研究旨在主观评估Vicks <$VapoRub <$（VVR）软膏和对照软膏（凡士林）在控制URI儿童夜间咳嗽和感冒症状方面是否优于无治疗。 它还将确定治疗对URI儿童及其父母睡眠质量的影响。